Balance Sheet

Cash Flow Statement

Acquisitions Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Masco (MAS) Asset Writedowns and Impairment (2025)

Masco's Asset Writedowns and Impairment history spans 5 years, with the latest figure at $5.0 million for Q4 2025.

For Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $5.0 million; the TTM value through Dec 2025 reached $27.0 million, changed N/A, while the annual FY2025 figure was $5.0 million, N/A changed from the prior year.
Asset Writedowns and Impairment reached $5.0 million in Q4 2025 per MAS's latest filing, up from $4.0 million in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $5.0 million in Q4 2025 to a low of $5.0 million in Q4 2025.